Boxes of Zantac 150 ranitidine tablets acid reducer for sale on a pharmacy shelf. Credit: calimedia/Shutterstock More Than 200 Superior Court Suits Link Zantac to Cancer
Dozens of plaintiffs are named in each case, which were filed from Aug. 23 to 26.
August 29, 2022 at 04:37 PM
3 minute read
Pharmaceuticals
The original version of this story was published on Delaware Law Weekly
More than 200 product liability cases claiming Zantac and its generic forms caused people to develop cancer were filed in Delaware Superior Court over the course of several days.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
